This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,420.70 firm fixed-price delivery order is for HAVRIX 1,440 unit/mL syringes, with a performance period running through January 22, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.30 firm fixed-price delivery order contract is for the supply of HAVRIX 1,440 unit/mL syringes, with an ultimate completion date of October 29, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,417.50 firm-fixed-price delivery order is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical products, with a completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of Havrix 1,440 units/mL syringes to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,664.93 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,389.95 fixed-price delivery order contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medical products, with a completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,854.50 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medical products, with a period of performance through October 2024. The contract was competitively awarded and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,887.20 firm fixed-price delivery order is for the procurement of HAVRIX 720 Unit/0.5 mL syringe medical supplies. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,260.92 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medical products. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $21,214.10, is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, for the provision of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a Firm Fixed Price pricing type and an Ultimate Completion Date of May 2, 2024. The award does not have a Set-Aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,400.64, is a delivery order for the medical product "HAVRIX 1,440 UNIT/ML SYRINGEML". The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...